Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children

NCT02836431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Heart Disease

Interventions

DRUG: Dexmedetomidine 1mcg/kg Intranasal
DRUG: Dexmedetomidine 2mcg/kg Intranasal
DRUG: Dexmedetomidine 1mcg Intravenous

Sponsor

Children's Hospital Medical Center, Cincinnati